Active Surveillance in Prostate Cancer: Current and Potentially Emerging Biomarkers for Patient Selection Criteria.

导出 LinkOut

翻译打印收藏纠错

作者： Paula C,Sotomayor ^[1] ; Juan C,Aguilar ^[2] ; Karen,Mujica ^[3] ; Alvaro,Zuñiga ^[3] ; Alejandro S,Godoy ^[4] ; Gary J,Smith ^[5] ; James L,Mohler ^[5] ; Gonzalo,Vitagliano ^[5] ; Ignacio F,San Francisco ^[2]

作者单位： Department of Urology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile, paulasotomayorf@gmail.com. ^[1] Department of Urology, Hospital Alemán, Buenos Aires, Argentina. ^[2] Department of Urology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. ^[3] Center for Cell Biology and Biomedicine, Faculty of Medicine and Science, Universidad San Sebastián, Santiago, Chile. ^[4] Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA. ^[5]

关键词 Active surveillance Biomarkers Prostate Prostate cancer

主题词人类(Humans);男(雄)性(Male);病人遴选(Patient Selection);生活质量(Quality of Life);观察性等待(Watchful Waiting);前列腺肿瘤(Prostatic Neoplasms)

DOI 10.1159/000527151

PMID 36349773

发布时间 2022-12-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交